Can a buddy app slash hospital readmissions for liver patients?
NCT ID NCT02534805
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a smartphone app called PatientBuddy designed to help people with cirrhosis and their caregivers manage care at home. The goal was to reduce avoidable hospital readmissions within 30 days after discharge. Researchers enrolled 232 patients and their caregivers to see if the app made a difference.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PatientBuddy smartphone app
- What this could lead to
- If it works, this app could help cirrhosis patients avoid unnecessary return trips to the hospital.
- What could go wrong
- This is a single-center study with 232 participants, so results may not apply to all patients. The app requires a caregiver living in the same home, which limits who can use it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Virginia Commonwealth University
Richmond, Virginia, 23298, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can everyday drugs shield the liver from Cirrhosis's worst threats?
- Could a yellow tinge predict dangerous hospital infections?
- Muscle quality on MRI may foretell liver transplant success
- Melatonin may ease sleep and brain fog in liver disease — a trial puts it to the test
- Heart scans could uncover silent damage in liver patients awaiting transplant
- Could the Body's largest vein replace a Hard-to-Reach one for liver pressure checks?